The dangers of sclerotherapy in the treatment of ganglia.
Sixteen ganglia were treated by injection with sclerosant (Sodium Tetradecyl Disulphate), fifteen failed to respond. We present radiological and electron microscopical data together with animal studies to explain the failure and to show the inherent dangers of this therapy.
D000818:Animals; D002645:Chickens; D005233:Fatty Alcohols / Q000009:adverse effects*; D005347:Fibroblasts / Q000473:pathology; D006801:Humans; D007719:Knee Joint / Q000473:pathology*; D010950:Plasma Cells / Q000473:pathology; D051381:Rats; D012597:Sclerosing Solutions / Q000009:adverse effects* / Q000627:therapeutic use; D012981:Sodium Tetradecyl Sulfate / Q000009:adverse effects* / Q000627:therapeutic use; D013581:Synovial Cyst / Q000628:therapy* / Q000648:ultrastructure; D013710:Tendons / Q000473:pathology*; D014953:Wrist
D005233:Fatty Alcohols; D012597:Sclerosing Solutions; D012981:Sodium Tetradecyl Sulfate